146 related articles for article (PubMed ID: 38496902)
1. Multidimensional pan-cancer analysis of HSPA5 and its validation in the prognostic value of bladder cancer.
Wang Y; Wang J; Liu Y; Wang X; Ren M
Heliyon; 2024 Mar; 10(6):e27184. PubMed ID: 38496902
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
[TBL] [Abstract][Full Text] [Related]
3. A new survival model based on ferroptosis-related genes (FRGS) for prognostic prediction in bladder cancer.
Yang Y; Hu H; Chen L; Zhang H; Yang J
Actas Urol Esp (Engl Ed); 2022 Oct; 46(8):494-503. PubMed ID: 35780051
[TBL] [Abstract][Full Text] [Related]
4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
5. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
6. A human pan-cancer system analysis of heat shock protein family A member 5.
Deng C; Gong S; Lin L; Tang J; Pang X; Wu P
Am J Cancer Res; 2023; 13(5):1698-1717. PubMed ID: 37293179
[TBL] [Abstract][Full Text] [Related]
7. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
8. HSPA5 Could Be a Prognostic Biomarker Correlated with Immune Infiltration in Breast Cancer.
Zhang C; Liu Q; Zhou Y; Hua J; Su R; Ai J
Dis Markers; 2022; 2022():7177192. PubMed ID: 36193502
[TBL] [Abstract][Full Text] [Related]
9. Identification and prognostic analysis of ferroptosis‑related gene HSPA5 to predict the progression of lung squamous cell carcinoma.
Guo D; Feng Y; Liu P; Yang S; Zhao W; Li H
Oncol Lett; 2024 Apr; 27(4):186. PubMed ID: 38464337
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
Shen C; Fu C; Suo Y; Li K; Zhang Z; Yang S; Zhang Y; Lin Y; Li Z; Wu Z; Huang S; Chen H; Fan Z; Hu H
Heliyon; 2023 Jun; 9(6):e16897. PubMed ID: 37346342
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
Front Oncol; 2023; 13():972558. PubMed ID: 37064115
[TBL] [Abstract][Full Text] [Related]
12. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value and Immunological Role of the HSPA5 Gene in Cervical Cancer.
Bai Y; Miao Y; Wang J; Gan J; Feng J
Biochem Genet; 2024 Apr; ():. PubMed ID: 38584219
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma.
Wang Y; Zhu H; Wang X
Front Genet; 2022; 13():965100. PubMed ID: 36186448
[No Abstract] [Full Text] [Related]
16. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
Sun X; Xin S; Jin L; Zhang Y; Ye L
Bioengineered; 2022 May; 13(5):13986-13999. PubMed ID: 35758021
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate.
Wang Z; Huang R; Wang H; Peng Y; Fan Y; Feng Z; Zeng Z; Ji Y; Wang Y; Lu J
Front Genet; 2022; 13():842975. PubMed ID: 35656324
[TBL] [Abstract][Full Text] [Related]
18. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer.
Pan G; Xie H; Xia Y
Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of the Oncogenic and Immunological Role of
Ding J; Meng Y; Han Z; Luo X; Guo X; Li Y; Liu S; Zhuang K
Front Oncol; 2022; 12():811567. PubMed ID: 35651805
[TBL] [Abstract][Full Text] [Related]
20. TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer.
Tang R; Wang H; Liu J; Song L; Hou H; Liu M; Wang J; Wang J
Eur J Med Res; 2024 Feb; 29(1):112. PubMed ID: 38336764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]